|
Duke-Margolis Welcomes Summer Interns
Duke University students Daniel Feingold, Yuna Kim, Grant McHorse, Megan Moore, Rishi Sachdev, and James Madison University student Phillip Wong are working on a variety of health policy projects this summer at Duke-Margolis' offices in Durham, NC and Washington, DC.
Read more
|
|
|
Duke-Margolis updates will take a hiatus in July. We look forward to connecting with you in August and wish you a safe and healthy summer!
To update your email address and continue to receive notice of Duke-Margolis events and research, please visit our web site.
|
|
Study Creates Benchmarks for Evaluating Community-Based Palliative Care
Use of palliative care, an interdisciplinary approach to caring for individuals with life-limiting illness focused on improving quality of life, is increasing as our population ages and evidence about its benefits grows. However, there is still little information about which care activities are necessary for delivering high-quality palliative care in the community.
A team led by Nrupen Bhavsar, PhD, MPH, of Duke’s division of general internal medicine and Donald H. Taylor, Jr, PhD, of the Duke Clinical Research Institute, Duke-Margolis and the Sanford School of Public Policy, worked with partners at Four Seasons Hospice organization to conduct a time and motion study at three care settings, resulting in a detailed process map. The team calculated the time spent on patient care, administrative duties, care coordination, and other activities. Read More
|
|
The Tower Of Babel In Clinical Research: PCORnet’s Common Data Model Cracks The Foundation
Across all medical specialties, there is a severe lack of high-quality clinical evidence, in part because the gold standard for evidence is large-scale randomized controlled clinical trials. Such trials are on an unsustainable cost trajectory, as they require expensive, stand-alone data capture infrastructures. Furthermore, they typically enroll highly selected populations that are not necessarily representative of real-world patients. Although the emergence of the electronic health record (EHR) holds great promise for generating much-needed evidence, medical research lags far behind other industries in its ability to use big data to get the answers decision makers need in health care. The ability to harness good quality, usable data from EHRs will likely be as revolutionary to health care as the Internet was to other industries. Read more from Lesley Curtis, PhD, in Health Affairs.
|
|
Financing international collective action for epidemic and pandemic preparedness
In a comment published online in Lancet Global Health, Gavin Yamey, MD, MPH, and other participants in a workshop held at the National Academy of Medicine by the Duke Center for Policy Impact in Global Health and the Coalition for Epidemic Preparedness Innovations (Oslo, Norway), experts recommend strengthening international cooperation and preparedness by financing public health capacity, including human and animal disease surveillance, and supporting global efforts to accelerate research and development of vaccines, drugs, and diagnostics for outbreak control, and to strengthen the global and regional outbreak preparedness and response system. Read More
|
|
|
What U.S. Hospitals Can Still Learn from India’s Private Heart Hospitals
Read more from Barak D. Richman, JD, PhD, & Kevin A. Schulman, MD, MBA, in the New England Journal of Medicine's Catalyst.
|
|
Duke-Margolis and Duke Medicine Collaborators Present at Academy Health
Robert Saunders, PhD, Azalea Kim, MD, MPH, MBA, and
William Bleser, PhD, (pictured here with their poster) were just some of the presenters at Academy Health's 2017 Research Meeting held June 25-27 in New Orleans, LA.
|
|
|
Exchange Uncertainty
David Anderson proposes four options to improve the health information exchanges for 2019 open enrollment in
STAT First Opinion.
|
|
|
Pandemics and the Poor
Duke-Margolis and DGHI member Gavin Yamey and Ben Oppenheim of the Brookings Institution, co-authored a blog post putting forward a four-point plan for protecting the poor from pandemic disease outbreaks. Pandemics disproportionately affect the poor, in terms of morbidity and mortality and in terms of economic circumstances. Read more
|
|
|
Thought Leadership
Duke-Margolis Director Mark B. McClellan, MD, PhD, moderated a flagship panel and Deputy Director Gregory Daniel, PhD, presented policy proposals for providing incentives for development of new antimicrobial drugs in several sessions at the 2017 BIO International Convention in San Diego on June 21. Dr. Daniel was an invited speaker for the National Academics of Medicine's workshop on combating antimicrobial resistance. Dr. McClellan also appeared on a panel with Research!America, "A world without disease: can we get there?"
|
|
|
mHealth: Is there evidence within the excitement?
Duke-Margolis has launched an expert working group to tackle how to make data derived from consumer and clinical-use mobile apps and wearables as part of our ongoing work to support real-world evidence. While mHealth apps and wearables have the potential to substantially improve our ability to manage and treat a wide variety of conditions, there are a wide range of challenges in making the data useable for research purposes. Over the summer, the working group will develop an action plan that will identify the how innovators in health technology, research and consumer technologies can collaborate to advance use of these tools to support improved health outcomes and the public health. To gather feedback from the perspective of patients, researchers, and app developers, Duke-Margolis
hosted a webinar on June 26th to collect public comments on the potential for use of mHealth data in secondary research. Slides from the webinar are available on the website and additional comments from the public are welcome. Please email comments to
[email protected] by July 12, 2017.
|
|
|
Real World Evidence - it's not just for label expansions
Duke-Margolis, under a cooperative agreement with FDA, convened stakeholders from patient groups, government, providers, payers, industry and academia in
an expert workshop on April 26th to review the use of real-world evidence throughout the total product lifecycle of medical devices and identify current gaps in real-world evidence generation. This event was planned and held in coordination with the
National Evaluation System for health Technology’s (NEST) coordinating center (based at MDIC), to help determine initial priorities for the center.
|
|
|
Exploring outcomes and Value across the Spectrum of Alzheimer’s Disease
Alzheimer’s disease is devastating for both patients and their families. As the population ages, this disease also places a disproportionate financial burden on society, and costs are expected to spiral over the next decade. Potential new therapies are beginning to target early stages of disease, even before symptoms are present, as well as targeting existing symptomatology. As a result, payers will need to explore new approaches to identify potential patient populations and re-evaluate the types of evidence that define treatment success. In collaboration with The Global CEO Initiative on Alzheimer’s Disease (CEOi), the Duke-Margolis Center for Health Policy convened an expert workshop on June 20, moderated by Dr. Greg Daniel, to understand how to better capture meaningful outcomes for patients and caregivers that could inform future payment models.
|
|
|
The Duke-Margolis Center for Health Policy's mission is to improve health and the value of health care by developing and implementing evidence-based policy solutions locally, nationally, and globally.
Our work is focused on three themes:
|
|
|
If you are interested in supporting health policy research at Duke University,
visit our website.
This newsletter is published monthly by the Robert J. Margolis, MD, Center for Health Policy at Duke University.
|
|
|
|
|
|
|
